Cuba announces its vaccine candidate is authorized to begin Phase 3 trials
From CNN’s Patrick Oppmann
A technician works with the Soberana 02 Covid-19 vaccine at the Finlay Vaccine Institute in Havana, Cuba, on January 20. Yamil Lage/Pool/AP
Cuban scientists announced that the island’s Soberana vaccine candidate had received authorization to begin phase three trials immediately.
A second vaccine Abdala would also begin phase three trials soon, scientists said.
While many developing countries have struggled to import vaccines, Cuba has focused on making their own as a way to raise money and instill national pride in the island’s bio-medical industry.